Results 131 to 140 of about 77,174 (152)

Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial

Autophagy, 2021
Pieter Wesseling, Philippe Lambin
exaly  

Comprehensive pharmacogenomics characterization of temozolomide response in gliomas

European Journal of Pharmacology, 2021
Jian Wu, Jianfei Long
exaly  

A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients

Annals of Oncology, 2009
M Pfirrmann, G Schackert, T Illmer
exaly  

Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas

Annals of Oncology, 2003
Michael Brada, S Ashley
exaly  

Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada – Clinical Trials Group (NCIC-CTG)

Annals of Oncology, 2006
M Crump, M E Trudeau, L Bordeleau
exaly  

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†

Annals of Oncology, 2014
Luc Taillandier, D Frappaz, R Schott
exaly  

First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)

Annals of Oncology, 2012
Silke Gillessen, Reinhard Dummer, O Michielin   +2 more
exaly  

Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation

Annals of Oncology, 2014
Manuela Gariboldi, Claudia Maggi, Elena Tamborini   +2 more
exaly